Sirio Pharma
SZSE · 300791
Market Cap$5.3B
Revenue$4.3B
Employees2776
Listed OnSZSE
Ticker300791
CEO / ExecMr. Peiqing Li
HeadquartersShantou
MarketMainland China
Websitewww.siriopharma.com
Overview
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.